Sclerotherapy is one of the most common and least-invasive treatment methods for varicose veins. While bench-top properties of sclerosing foams (e.g., bubble size distribution and foam half-life) have been studied previously, their flow behaviour and its relationship to therapeutic efficacy remain largely uncharacterised. To address this research gap, the present study reports on a novel approach for the rheological characterisation of sclerosing foams aimed at obtaining clinically-applicable data. A pipe viscometry apparatus was employed under conditions that mimic the end-point therapeutic application of foams. Polidocanol (1% v/v) foams of various liquid-to-gas volume ratios (1:3, 1:4 and 1:5) were formulated manually using the Tessari a...
ObjectivesTo determine the effects of sclerosant foam preparation and composition on foam structure,...
Introduction: Primary varicose veins are common with a multitude of non-optimal treatments. Foam scl...
AbstractObjectiveTo compare the relative efficacy of polidocanol (Aetoxisclerol®, Kreussler, Germany...
Sclerotherapy is among the least invasive and most commonly utilised treatment options for varicose ...
Varicose veins are chronic venous defects that affect >20% of the population in developed countri...
Foam sclerotherapy is clinically employed to treat varicose veins. It involves intravenous injection...
Foam sclerotherapy is clinically employed to treat varicose veins. It involves intravenous injection...
We have recently reported on the development of a biomimetic vein model to measure the performance o...
BACKGROUNDFoam sclerotherapy is the process of using an aqueous foam to deliver surfactant to a vari...
Sclerosant foam, a mixture of a surfactant liquid and air, is injected directly into varicose veins ...
A novel analysis system for the quantification of sclerosing foam properties under clinically releva...
Sclerotherapy is currently employed to effectively treat varicose veins, and relies on the injection...
Introduction The development of minimally invasive techniques for the treatment of varicose veins is...
AbstractObjectiveTo assess the efficacy and safety of sclerotherapy performed with polidocanol foam ...
AbstractIntroductionLower extremity varicose vein is a common disease. Sclerotherapy can be used to ...
ObjectivesTo determine the effects of sclerosant foam preparation and composition on foam structure,...
Introduction: Primary varicose veins are common with a multitude of non-optimal treatments. Foam scl...
AbstractObjectiveTo compare the relative efficacy of polidocanol (Aetoxisclerol®, Kreussler, Germany...
Sclerotherapy is among the least invasive and most commonly utilised treatment options for varicose ...
Varicose veins are chronic venous defects that affect >20% of the population in developed countri...
Foam sclerotherapy is clinically employed to treat varicose veins. It involves intravenous injection...
Foam sclerotherapy is clinically employed to treat varicose veins. It involves intravenous injection...
We have recently reported on the development of a biomimetic vein model to measure the performance o...
BACKGROUNDFoam sclerotherapy is the process of using an aqueous foam to deliver surfactant to a vari...
Sclerosant foam, a mixture of a surfactant liquid and air, is injected directly into varicose veins ...
A novel analysis system for the quantification of sclerosing foam properties under clinically releva...
Sclerotherapy is currently employed to effectively treat varicose veins, and relies on the injection...
Introduction The development of minimally invasive techniques for the treatment of varicose veins is...
AbstractObjectiveTo assess the efficacy and safety of sclerotherapy performed with polidocanol foam ...
AbstractIntroductionLower extremity varicose vein is a common disease. Sclerotherapy can be used to ...
ObjectivesTo determine the effects of sclerosant foam preparation and composition on foam structure,...
Introduction: Primary varicose veins are common with a multitude of non-optimal treatments. Foam scl...
AbstractObjectiveTo compare the relative efficacy of polidocanol (Aetoxisclerol®, Kreussler, Germany...